Routine-screening population | | |
|
Age, years | | |
50–54 | 55 | 26.8 |
55–59 | 81 | 39.5 |
60–64 | 69 | 33.7 |
|
Menopausal statusa | | |
Pre-menopausal | 5 | 2.7 |
Peri-menopausal | 9 | 4.9 |
Post-menopausal | 150 | 82.4 |
Not reported/unknown | 18 | 9.9 |
|
Colposcopy population | | |
|
Age, years | | |
35–49 | 13 | 15.7 |
50–54 | 33 | 39.8 |
55–59 | 22 | 26.5 |
60–70 | 15 | 18.1 |
|
Reason for referral population study eligibility | | |
Confirmed CIN2+ on biopsy | 15 | 18.1 |
Moderate dyskaryosis on cytology | 9 | 10.8 |
Severe dyskaryosis on cytology | 4 | 4.8 |
HPV triageb | 55 | 66.3 |
|
Age of women with CIN2+, years | | |
35–49 | 5 | 27.8 |
50–54 | 6 | 33.3 |
55–59 | 3 | 16.7 |
60–70 | 4 | 22.2 |